Dcun1D3 inhibitors are a class of chemical compounds that specifically target and inhibit the Dcun1D3 protein, which is part of the Nedd8 conjugation pathway. Dcun1D3 is one of several members of the DCN1-like family of proteins, playing a significant role in facilitating the neddylation process-a post-translational modification where the ubiquitin-like protein Nedd8 is conjugated to specific substrates, primarily cullin proteins. This modification is essential for activating cullin-RING ligases (CRLs), which are involved in ubiquitination, a process that regulates protein degradation, cell cycle progression, and various other cellular processes. By inhibiting Dcun1D3, these compounds disrupt the neddylation pathway, affecting the activity of cullin-based E3 ligases and the overall regulation of protein turnover.
The mechanisms by which Dcun1D3 inhibitors function can vary. Some inhibitors might directly bind to the catalytic or interaction domains of Dcun1D3, preventing it from facilitating the neddylation of cullins. Others might interfere with its ability to interact with other components of the Nedd8 conjugation machinery, thus inhibiting the assembly or function of the CRLs. Dcun1D3 inhibitors are valuable tools for understanding the intricate roles of the Nedd8 pathway in cellular homeostasis and protein regulation. By blocking the action of Dcun1D3, researchers can investigate the broader implications of neddylation on cellular signaling, protein stability, and the intricate control of protein degradation pathways, leading to insights into how cells regulate these essential processes at the molecular level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
Inhibits NEDD8-activating enzyme (NAE), reducing neddylation, which can affect Dcun1D3-involved protein degradation. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor that can lead to accumulation of proteins targeted for degradation, potentially involving Dcun1D3. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Modulates various signaling pathways and can influence protein degradation systems that involve Dcun1D3. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that can lead to the build-up of proteins involved in neddylation process, potentially affecting Dcun1D3. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Lysosomal inhibitor that can alter the degradation pathways of proteins, which may include those associated with Dcun1D3. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that can alter signaling pathways and possibly influence Dcun1D3's role in protein degradation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that can affect multiple cellular processes, including protein degradation pathways involving Dcun1D3. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor that can change protein synthesis and degradation, potentially affecting Dcun1D3-related pathways. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Kinase inhibitor that can influence various signaling pathways, some of which may be linked to Dcun1D3's role. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor that can impact protein degradation pathways, potentially modifying the role of Dcun1D3. | ||||||